Speaking of Dr. Leia NghiemPhu, I also had the chance to hang out with her for a bit after the presentation that night back in February 2020 (featuring Bill Malloy’s wife Shenell who unfortunately has GBM). That’s the same night that I also was able to meet Dr Liau. Dr. Nghiemphu and I spoke at the end of the UCLA presentation for about five minutes one-on-one, too, and she confirmed how UCLA was using DCVax-L in the combo trial. But they just can’t call the vaccine DCVax-L because NWBO isn’t sponsoring the trial (because they haven’t the funds to do so). But because it’s UCLA, they can use the same formula in their own trials, but if UCLA makes it and it’s not supplied by Northwest, they have to call the vaccine by its generic name... autologous dendritic cell vaccine.
I’m not a lawyer, but I’m not sure if my claims could be considered hearsay, because I was a part of the actual conversation. I didn’t overhear these statements. I asked Dr. Liau if the vaccine they were using in the combo trial was really DCVax-L and she said, yes, that it was. I do trust my own ability to ask the question and my hearing of the answer, and I know others who read this do as well. So I think it’s more not a question of hearsay, but if I’m lying, so that’s really what I think Just the facts Jack may want to consider.
I will add that apparently Matt, who is actually in the UCLA combo trial and is recounting his personal experience on Twitter, has received the autologous dendritic call vaccine that he believes and is very happy to be DCVax-L . So that’s another question JTFJack may want to examine. Or is Matt also being mislead by UCLA? Or perhaps JTF Jack thinks Matt’s claims are all just hearsay, too?
AI
Market Data 
Markets 
